Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real‐World Evidence in New Drug and Biologics License Application Approvals During Fiscal Years 2020–2022

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3688Source: DataRank Database

Real‐World Evidence in New Drug and Biologics License Application Approvals During Fiscal Years 2020–2022 is a research paper published in Clinical Pharmacology & Therapeutics (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 9.52)OA: hybridTopics (19)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kimberly Smith ORCID,Aida Kuzucan ORCID,Jie Li ORCID,Donna R. Rivera ORCID,Orestis A. Panagiotou ORCID

Live enrichment

PubMed:40276902 PMC:PMC12167130 OpenAlex:https://openalex.org/W4409816201

Intramural FDA HHS

Grant: FD999999

FWCI

9.52

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: public-domain

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3688

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3688

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3688

journalhttps://doi.org/10.1002/cpt.3688

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40276902

Fields of Study

Health Systems, Economic Evaluations, Quality of LifeBiosimilars and Bioanalytical MethodsStatistical Methods in Clinical TrialsDrug ApprovalHumansUnited StatesUnited States Food and Drug AdministrationBiological Products

MeSH Terms

Biological ProductsHumansUnited StatesUnited States Food and Drug AdministrationDrug Approval

Keywords

MedicineLicenseFood and drug administrationBusinessPharmacologyComputer science